Acute bacterial meningitis in the intensive care unit and risk factors for adverse clinical outcomes: retrospective

D Fernandes1, J Gonçalves-Pereira2, S Janeiro3

  • 1Infectious Disease and Tropical Medicine Department, Egas Moniz Hospital, CHLO, Lisbon, Portugal; Polyvalent Intensive Care Unit, São Francisco Xavier Hospital, CHLO, Lisbon, Portugal.

Journal of Critical Care
|January 11, 2014
PubMed
Abstract

Insights

Bacterial meningitis in the ICU has high mortality. Low Glasgow Coma Scale (GCS) scores and absence of fever predict poor outcomes for these critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Neurology

Background:

  • Bacterial meningitis is a critical illness with significant morbidity and mortality.
  • Limited research exists on intensive care unit (ICU) admissions for bacterial meningitis and associated prognostic factors.
  • Understanding outcomes in immunocompromised and elderly populations is crucial.

Purpose of the Study:

  • To investigate the clinical impact and prognostic factors of acute bacterial meningitis in ICU patients.
  • To identify predictors of adverse clinical outcomes in this patient cohort.

Main Methods:

  • Retrospective analysis of patients over 18 years old admitted to two polyvalent ICUs over a 7-year period.
  • Collection of clinical, demographic, and outcome data.
  • Evaluation of prognostic factors for adverse outcomes.

Main Results:

  • 65 patients with acute bacterial meningitis were identified, with a 40% hospital mortality rate.
  • Common symptoms included fever (84%), seizures (21.5%), and low Glasgow Coma Scale (GCS) scores (58.4%).
  • Older age, higher Acute Physiology and Chronic Health Evaluation II scores, and lower GCS were associated with adverse outcomes. Fever upon admission predicted a better prognosis.

Conclusions:

  • Patients with acute bacterial meningitis admitted to the ICU experience substantial morbidity and mortality.
  • Low GCS scores and absence of fever are key indicators of a particularly high risk for adverse outcomes.
  • These findings highlight critical factors for risk stratification and management in ICU settings.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
15
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
199
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.5K